Well, that was much to do about nothing given the anticipation that came ahead of the trading week. When it was all said and done, the S&P 500 moved all of 5 points higher for the week and once again finished within its weekly expected move. What is truly remarkable about the drawdown from Q4 2018, through the current rally…
Still Growing, In Spite of Geopolitical Headwinds
A financial market resource for the every-day investor and trader.
-
Crazy Time For Markets and Investors
Seth Golden, , Research Reports, 0
In the past trading week, investors/traders were once again at the mercy of trade headlines. It was only 2...
-
Value Squeeze: J.P. Morgan Team
Seth Golden, , Research Reports, 0
US Equity Strategy Style Positioning, Value Squeeze, Winner Takes All Rising odds of a sharp Value squeeze in the...
-
Morgan Stanley Focus On Low Bar Set Up For 2020
Seth Golden, , Research Reports, 0
At first glance, U.S. equities seem to be riding a bullish wave. The S&P 500 is up more than...
-
Will Earnings Give The S&P 500 A Boost Above 3,000?
Seth Golden, , Research Reports, 0
Entering the trading week, we were of the opinion that the rally in the major averages from the previous...
-
J.C. Penney Issues A Disaster In Q1 And Shareholders Take It On The Chin
Seth Golden, , Research Reports, 0
J.C. Penney (JCP) reported an increasingly worrisome sales performance last week as the company put forth its Q1 2017...
-
Morgan Stanley Biotechnology Team: Year-End Vaccine Probable
Seth Golden, , Research Reports, 0
Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is...
-
Merrill Lynch: Expansion Cycle & Earnings Growth Will Continue
Seth Golden, , Research Reports, 0
Macro Strategy—Expansion and Profits Growth to Continue in 2022: Current Federal Reserve (Fed) projections and the leads and lags...
-
Target’s 2017 Ends As 2018 Begins: Reviewing Results & Guidance
Seth Golden, , Research Reports, 0
Earlier this month, Target released its Q4 2017 results alongside 2018 guidance. The release brought with it selling pressure...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00